Prostate Cancer - Results from #27600

Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence - Abstract June 28, 2011

Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS) - Abstract June 28, 2011

Treatment effects in the prostate including those associated with traditional and emerging therapies - Abstract June 28, 2011

Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens - Abstract June 28, 2011

Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer - Abstract June 28, 2011

Watchful waiting and active surveillance approach in patients with low risk localized prostatic cancer: An experience of out-patients clinic with 12-year follow-up - Abstract June 28, 2011

Patient centeredness and decision-making in localised prostate cancer : Possible fields of health services research in urology - Abstract June 28, 2011

Prostate-specific antigen velocity before and after elimination of factors that can confound the prostate-specific antigen level - Abstract June 27, 2011

Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer - Abstract June 27, 2011

Impact of hypoxia on the metastatic potential of human prostate cancer cells - Abstract June 27, 2011

Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: A systematic review - Abstract June 27, 2011

Mindfulness groups for men with advanced prostate cancer: A pilot study to assess feasibility and effectiveness and the role of peer support - Abstract June 27, 2011

The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: A population-based study - Abstract June 27, 2011

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease - Abstract June 27, 2011

Comparative evaluation of radiation treatments for clinically localized prostate cancer: An updated systematic review - Abstract June 27, 2011

Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer : Report of a case - Abstract June 27, 2011

Editor's Commentary - Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: The impact of time from surgery to recurrence June 27, 2011

Editor's Commentary - Salvage radiation in men after prostate-specific antigen failure and the risk of death June 27, 2011

How to select the best candidates for prostate biopsies? The role of traditional tools and contribution of new biomarkers in prostate cancer - Abstract June 26, 2011

Broadening horizons in medical management of prostate cancer - Abstract June 24, 2011

Page 1381 of 1436